AIG
IMRX icon

American International Group’s Immuneering IMRX Stock Holding History

American International Group’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,034
Closed -$31.9K – 1293
2024
Q1 		$31.9K Sell
11,034
-94
-0.8% -$527 ﹤0.01% 2870
2023
Q4 		$81.8K Sell
11,128
-45
-0.4% -$300 ﹤0.01% 2663
2023
Q3 		$85.8K Buy
11,173
+1,412
+14% +$13K ﹤0.01% 2587
2023
Q2 		$99K Buy
+9,761
New +$93.9K ﹤0.01% 2580
2022
Q2 		– Sell
-9,432
Closed -$61K – 3177
2022
Q1 		$61K Buy
9,432
+4,964
+111% +$47.7K ﹤0.01% 2777
2021
Q4 		$72K Sell
4,468
-58
-1% -$1.41K ﹤0.01% 2846
2021
Q3 		$120K Buy
+4,526
New +$122K ﹤0.01% 2717

Other funds holding IMRX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

American International Group's IMRX Position: Q2 2024 in Review

American International Group sold out of Immuneering (IMRX) in Q2 2024, closing a stake of 11,034 shares — an estimated $31.9K sold.

American International Group first reported a position in IMRX in Q3 2021 and held it in 7 quarters. The position peaked at $120K in Q3 2021. 59 funds tracked by Wall St. Rank hold IMRX as of Q2 2024.

  • American International Group reported no remaining Immuneering position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 11,034 Immuneering shares in Q2 2024, an estimated $31.9K.
  • American International Group first reported a position in Immuneering in Q3 2021 and held it in 7 quarters.
  • American International Group's Immuneering position peaked at $120K in Q3 2021.
  • 59 funds tracked by Wall St. Rank held Immuneering as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.